ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Clinical trials for ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double-Punch cancer trial: radiation and immune drugs team up
Disease control CompletedThis study tested whether combining a short, intense course of radiation with an immunotherapy drug could help control advanced head and neck cancer. It involved 21 adults whose cancer had returned or spread and was no longer curable with standard surgery or radiation. The goal w…
Matched conditions: ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New cancer drug injected directly into tumors shows promise in early trial
Disease control CompletedThis early-stage study tested a new drug, CyPep-1, which is injected directly into tumors. It was combined with the immunotherapy drug pembrolizumab to see if it could help control advanced head and neck cancer, melanoma, or triple-negative breast cancer. The main goals were to c…
Matched conditions: ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Cytovation AS • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug combo tested for Tough-to-Treat head and neck cancer
Disease control CompletedThis study tested a combination of two drugs, duvelisib and docetaxel, for people with advanced head and neck cancer that had returned or spread after their first treatment stopped working. The goal was to see if this new combination could help control the cancer. About 26 people…
Matched conditions: ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Glenn J. Hanna • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC